Delivery Order SPE2DH25D0001-SPE2D425F736V
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $10,590.00 on September 23, 2025, by the Defense Medical Supply Chain. The contract is for EG7+ cartridges and carries a fixed-price structure with economic price adjustment provisions. The award utilizes full and open competition with no set-aside designation. Performance will take place in North Chicago, Illinois, with an ultimate completion date of September 25, 2025. This delivery...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on June 30, 2025, valued at $6,877.00 for EG7+ cartridge supplies. The contract is fixed price with economic price adjustment provisions and will be performed in North Chicago, Illinois, with an ultimate completion date of July 2, 2025. This delivery order was awarded without a set-aside designation, indicating full and open competition. The funding agency is the Medical Supply Chain, a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on September 18, 2025, with a ceiling value of $1,166.25 for an EG7+ Cartridge under a fixed-price contract with economic price adjustment provisions. The delivery order has an ultimate completion date of September 22, 2025, and will be performed at Abbott's North Chicago, Illinois location. This award represents a child contract under a larger vehicle structure and was procured through full and...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,166.25 on September 23, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract covers the supply of EG7+ Cartridge products and utilizes fixed price pricing with economic price adjustment provisions. The work will be performed in North Chicago, Illinois, where Abbott maintains its primary headquarters. This delivery order was awarded without any set-aside...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,332.50 on July 15, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, calls for the delivery of EG7+ cartridge medical products to the place of performance in North Chicago, Illinois, with an ultimate completion date of July 17, 2025. This award represents a child...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,041.75 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of September 12, 2025. The contract covers CG8+ cartridge products and is structured as a fixed-price delivery order with economic price adjustment provisions. The award was made on September 10, 2025, with no set-aside designation, indicating full and open competition. Performance...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,472.50 by the Department of Defense's Medical Supply Chain on September 5, 2025, with completion expected by September 9, 2025. The contract, designated as 4569345436 and classified as a fixed-price delivery order with economic price adjustment provisions, calls for the supply of CG8+ cartridges to support federal healthcare operations. The work will be performed at Abbott's facility in...
- Abbott Laboratories Inc., through its Abbott Point of Care division, received a delivery order award on September 11, 2025, valued at $1,646.25 for CG8+ cartridges from the Medical Supply Chain, a defense-focused federal agency. The contract employs fixed-price pricing with economic price adjustment mechanisms and will be performed in North Chicago, Illinois, with an ultimate completion date of September 15, 2025. No set-aside designation was used in this award, indicating full and open...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,130.88 on August 29, 2025, by the Defense Logistics Agency's Medical Supply Chain organization. This fixed-price delivery order with economic price adjustment features a completion date of September 3, 2025, and will be performed at Abbott's facility in North Chicago, Illinois. The contract pertains to cartridge analysis and testing components, consistent with Abbott's core business...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,247.84 on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract, designated as a Fixed Price with Economic Price Adjustment delivery order, calls for the supply of CG8+ cartridges to support federal healthcare operations. The work will be performed in North Chicago, Illinois, with an ultimate completion date of September 8, 2025. This award was...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D425F736VDelivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,625.00 on September 23, 2025, for an EG7+ Cartridge under a fixed-price contract with economic price adjustment provisions. The contract, which is scheduled for completion by September 25, 2025, will be performed in North Chicago, Illinois. The award was made without a set-aside designation, indicating full and open competition. This delivery order is funded by the Defense-affiliated Medical Supply Chain agency and represents Abbott's continued provision of point-of-care diagnostic testing products to federal healthcare procurement channels. Abbott Laboratories Inc. is an established supplier within the federal healthcare contracting ecosystem, with a robust portfolio of medical diagnostic equipment and in-vitro diagnostic products supplied primarily to the Department of Veterans Affairs and Defense Logistics Agency. The company maintains multiple Blanket Purchase Agreements under General Services Administration schedules, including the Critical Analyzers, Laboratory and In-Vitro Diagnostics, Reagents, Test schedules. This delivery order for the EG7+ Cartridge aligns with Abbott's core business of supplying specialized diagnostic reagents and testing supplies to support federal medical operations. As a child entity of Abbott Laboratories Inc., Abbott Point of Care continues to fulfill the company's mission of delivering comprehensive diagnostic solutions to government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/23/25 |